According to Enochian Biosciences's latest financial reports the company's current EPS (TTM) is -$2.02. In 2022 the company made an earnings per share (EPS) of -$2.06 a decrease over its 2021 EPS that were of -$0.79.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.02 | -1.94% |
2022 | -$2.06 | 160.76% |
2021 | -$0.79 | 243.48% |
2020 | -$0.23 | 43.75% |
2019 | -$0.16 | -74.87% |
2018 | -$0.64 | 339.47% |
2017 | -$0.14 | -48.26% |
2016 | -$0.28 | -22.22% |
2015 | -$0.36 | 7.39% |
2014 | -$0.34 | 4351.27% |
2013 | -$0.007531 | 16.6% |
2012 | -$0.006459 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 7.92% | ๐บ๐ธ USA |